Date: 2013-11-05
Type of information: Collaboration agreement
Compound: international fellowship programme
Company: Novo Nordisk (Denmark) Oxford University (UK)
Therapeutic area: Metabolic diseases
Type agreement: collaboration
Action mechanism:
Disease: diabetes
Details: * On November 5, 2013, Oxford University and Novo Nordisk have announced the establishment of an international fellowship programme that aims to support the career and scientific development of young, exceptional research talent within diabetes. The partnership will establish a number of postdoctoral fellowship opportunities that will be hosted by Oxford University and funded by Novo Nordisk. As part of the agreement, a total of 12 young leading researchers will be offered a 3-year grant to support their research within the fields of diabetes, metabolism and endocrinology. The goal of the new programme is to support the development of a new generation of research leaders while further developing scientific excellence within diabetes. A joint steering committee with members from both Oxford University and Novo Nordisk will oversee the programme and assess research proposals from scientists at both organisations.
The first four fellows in the programme will start in the autumn of 2014.
Financial terms:
Latest news:
